Higher CEA levels in patients with colorectal cancer are indicative of aggressive tumour phenotypes and survival Evidence ...

“Our new biochip device is low-cost — just a few dollars — and sensitive, which will make accurate disease diagnosis ...

bunyarit – stock.adobe.com Using a drop of blood from a patient, the PiPP targets two cancer markers: carcinoembryonic antigen (CEA), which is linked to colorectal cancer, and prostate-specific ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

Pancreaticobiliary cytopathology has emerged as a critical diagnostic tool, especially in evaluating pancreatic and bile duct lesions. Traditionally ...

The drug, which targets carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) on tumour cells, was unable to improve progression-free survival in the CARMEN-LC03 trial in previously ...

It is a CD40 bispecific antibody targeting both CD40 and CEA (carcinoembryonic antigen), a protein found in certain tumors but not in normal tissue. This approach is expected to improve both ...

The data contain efficacy results and correlative outcomes with biomarkers based on a median follow-up of 18 months in OPTIMIZE-1 trialConfirmed ORR of 42.1%, unprecedented median DoR of 12.6 months ...